SVP Clinical Research & Medical Affairs, Confidential Pharma. Focus on NDDS. 

Medical Doctor with Interest: #COVID19. (#Repurposing, Vaccines, [including Warp Speed], Biologics, Drugs, [including WHO SOLIDARITY], Trials, Nutraceuticals & Diagnostics) 

Have previously worked on Mycobacterium w: Cancer and Sepsis (TLR modulator, Cadila Pharma, "Leprovac", "Immuvac", "Sepsivac": in trials for COVID at PGI Chandigarh).

Prior work on Biocon’s “CytoSorb” [Approved for COVID] and "Alzumab", Itolizumab (anti-CD6 MAb of IgG1 isotype, Now in trials for COVID-19 at KEM, Mumbai)

Formerly:

Global Program Clinical Head at Novartis (looking after Galvus, Diovan, Co-Diovan, Exforge, Exforge-HCT, etc). 

 MD Internal Medicine ( Christian Medical College, CMC, Ludhiana, India)
MBBS (CMC Vellore, India)
•    + 18 years managerial & research (Corporate & Advocacy)
•    + 5+3 years clinical experience (Not For Profit, frontline Hospital & Healthcare Research Sector)
•    4+ PhD Theses Guided; 51+ Publications 
•    Creation & Drug Development and RCT of "Polycap" Polypill("The Indian Polycap Study", TIPS1 n=2053; Wellcome-Trust-supported "The International Polycap Study 3" TIPS3 in ten countries, n=5,713; McMaster University); global strategy for IV ("Rabeloc") Rabeprazole. CT for Rabies (Novavax; n=800), Influenza Viral Vaccine (Novavax). 

Member American Gastroenterological Association Academy of Educators. 

Strategy and Consulting and BD: Clinical Research in Phase I to IV in NCE, NDDS, New FDC, Repurposing, New Indications, Medical Devices, Immunologicals, Vaccines & Biologicals. 
Advocacy and partnerships. Medical Communication Expert. Innovator/ Early Adapter Tech Guru. E.g. Google Glasses; RDC BYOD.
Pianist, Baritone: Italian Classical, Gospel, Jazz and Blues Singer.
"Discovery consists of seeing what everybody has seen and thinking what nobody else has thought" -Nobel Prize winner 1934, Albert Szent-Györgyi (Jonathan Swift)